Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Joseph Wolk
Age : 53
Public asset : 4,319,420 USD
Country of residence : Unknown
Linked companies : Johnson & Johnson

Biography of Joseph Wolk 
Joseph J. Wolk holds the position of Chief Financial Officer & Executive Vice President at Johnson & Johnson. Mr. Wolk is also Member of Cnbc Global Cfo Council. Mr. Wolk received an undergraduate degree from St. Joseph's University and a graduate degree from Temple University Beasley School of Law.


Current positions of Joseph Wolk 
Holdings of Joseph Wolk 
Joseph Wolk : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
01:05pCATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
01:48pELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/15JARED ISAACMAN : Stock Futures Tick Up After Market Pullback
DJ
More news


© 2021 People and Ownership :   
Joseph Wolk : Connections 


Latest news about Joseph Wolk 
07/21J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target
RE
07/21JOHNSON & JOHNSON : Lifts Full-Year Guidance as Second-Quarter Results Beat Street Expectations
MT
07/21ASTRAZENECA : J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target
RE
06/22Even after Biden tax hike, U.S. firms would pay less than foreign rivals
RE
04/20J&J to resume rollout of COVID-19 vaccine in Europe with safety warning
RE
More news